-
Je něco špatně v tomto záznamu ?
Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods
M. Dvorakova, K. Kejlová, M. Rucki, D. Jírová,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články
- MeSH
- alfa receptor estrogenů metabolismus MeSH
- androgenní receptory metabolismus MeSH
- androgeny metabolismus MeSH
- biotest metody MeSH
- endokrinní disruptory metabolismus MeSH
- estrogeny metabolismus MeSH
- lidé MeSH
- receptory pro estrogeny metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: The aim of this study was to detect endocrine disruption potential of selected bisphenols and phthalates, compare in silico prediction with results from two in vitro methods and bring up-to-date information on development of EU legislation, available in vitro methods and biomechanisms involved in endocrine disruption. MATERIAL AND METHODS: In silico approach based on the OECD QSAR Toolbox was used for prediction of estrogen receptor α binding. OECD TG 455 assay and a yeast-based YES/YAS assay was used to determine the interactions with human estrogen (ERα) and androgen receptors. RESULTS: In silico results predicted the screened phthalates as non binders and bisphenols as very strong binders of the ERα. In vitro results differed from in silico prediction in several cases but exhibited concordance mainly for strong binders of ERα. Most of the substances exhibited parallel activity (agonist-antagonist) on both estrogen and androgen receptors. Agonistic studies showed the effective concentration of 10% activity (EC10) from 5.0E-07 for strong agonists (e.g. BPC, BPTMC). Cytotoxicity was observed after 48 h exposure of S. cerevisiae to BPFL, BPG, BPM, BPTMC in concentrations starting at 3.6E-05 mol/l. CONCLUSION: Our results suggest multiple parallel interactions of tested compounds and emphasize the importance of determination of an appropriate battery of in vitro methods that will include more receptors and will be appropriate to target specific molecular mechanisms involved in endocrine disruption. Results in agonistic studies indicate agonistic potential and are supported by results of antagonistic studies with consideration of possible multiple interactions.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034806
- 003
- CZ-PrNML
- 005
- 20191015101256.0
- 007
- ta
- 008
- 191007s2018 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)30664347
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Dvorakova, Marketa $u Charles University in Prague, Third Faculty of Medicine, Ruská 87, Prague, Czech Republic.
- 245 10
- $a Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods / $c M. Dvorakova, K. Kejlová, M. Rucki, D. Jírová,
- 520 9_
- $a OBJECTIVES: The aim of this study was to detect endocrine disruption potential of selected bisphenols and phthalates, compare in silico prediction with results from two in vitro methods and bring up-to-date information on development of EU legislation, available in vitro methods and biomechanisms involved in endocrine disruption. MATERIAL AND METHODS: In silico approach based on the OECD QSAR Toolbox was used for prediction of estrogen receptor α binding. OECD TG 455 assay and a yeast-based YES/YAS assay was used to determine the interactions with human estrogen (ERα) and androgen receptors. RESULTS: In silico results predicted the screened phthalates as non binders and bisphenols as very strong binders of the ERα. In vitro results differed from in silico prediction in several cases but exhibited concordance mainly for strong binders of ERα. Most of the substances exhibited parallel activity (agonist-antagonist) on both estrogen and androgen receptors. Agonistic studies showed the effective concentration of 10% activity (EC10) from 5.0E-07 for strong agonists (e.g. BPC, BPTMC). Cytotoxicity was observed after 48 h exposure of S. cerevisiae to BPFL, BPG, BPM, BPTMC in concentrations starting at 3.6E-05 mol/l. CONCLUSION: Our results suggest multiple parallel interactions of tested compounds and emphasize the importance of determination of an appropriate battery of in vitro methods that will include more receptors and will be appropriate to target specific molecular mechanisms involved in endocrine disruption. Results in agonistic studies indicate agonistic potential and are supported by results of antagonistic studies with consideration of possible multiple interactions.
- 650 _2
- $a androgeny $x metabolismus $7 D000728
- 650 _2
- $a biotest $x metody $7 D001681
- 650 _2
- $a endokrinní disruptory $x metabolismus $7 D052244
- 650 _2
- $a alfa receptor estrogenů $x metabolismus $7 D047628
- 650 _2
- $a estrogeny $x metabolismus $7 D004967
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a androgenní receptory $x metabolismus $7 D011944
- 650 _2
- $a receptory pro estrogeny $x metabolismus $7 D011960
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kejlová, Kristina $u National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 48, Prague, Czech Republic.
- 700 1_
- $a Rucki, Marian $u National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 48, Prague, Czech Republic.
- 700 1_
- $a Jírová, Dagmar $u Charles University in Prague, Third Faculty of Medicine, Ruská 87, Prague, Czech Republic.
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 39, č. 5 (2018), s. 409-416
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30664347 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191015101722 $b ABA008
- 999 __
- $a ok $b bmc $g 1451466 $s 1073356
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 39 $c 5 $d 409-416 $e - $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20191007